Żołnierek J. The first line therapy for intermediate/ high risk patients with advanced renal cell carcinoma according to therapeutic program B.10. OncoReview [Internet]. 2023Aug.19 [cited 2024Nov.22];13(2(50):48-7. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/2849